Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Search for stocks (e.g., AAPL, GOOGL, AMZN)
ABOS logo

ABOS

NGS
Acumen Pharmaceuticals Inc.
Professional, Scientific, and Technical ServicesResearch and Development in Biotechnology
Watchlists:
Last updated: Monday 14th July 2025
1.40
+0.10 (7.69%)
Prev Close:1.3
Open:1.31
Bid:1.4
Ask:1.45
52 Week Range
0.86
3.60
Volume:357,521
Mkt Cap:73 M
Price Target
$1.61
+15.0%
Financials

Financial Statements

ABOS - Income Statement (Annual)

Dec-24Dec-23Dec-22Dec-21Invalid date
Gain On Sale Of Security2 M-1 M
General And Administrative Expense20 M19 M13 M7 M
Gross Profit Margin (profit Margin After CGS)5000.043000.066000.0
Interest Expense Non Operating581000.0
Interest Income Operating11 M2 M
Misc Other Special Charges-151000.0-83000.0-11000.0-81 M
Net Income (loss)-102 M-52 M-43 M-101 M
Net Income Common Stockholders-102 M-52 M-43 M-101 M
Net Income Continuous Operations-102 M-52 M-43 M-101 M
Net Non Operating Interest Income Expense14 M11 M-2 M84000.0
Normalized Income-97 M-79 M
Operating Income-114 M-61 M-45 M-20 M
Operating Income Before Depreciation (EBITDA)-102 M-52 M-43 M-100 M
Operating Expense114 M61 M45 M20 M
Other Gand A20 M19 M13 M7 M
Other Operating Expenses160000.0154000.0
Rent And Landing Fees147000.0
Research Expense94 M42 M32 M12 M
Salaries And Wages10 M6 M
Total Income Available For Interest Expense (EBIT)-102 M-52 M-43 M-101 M
Total Revenues5000.043000.066000.0
Total Expenses114 M61 M45 M20 M
Total Revenue5000.043000.066000.0
Avgshs60 M49 M41 M20 M
Avgshsdt60 M49 M41 M20 M
Basiceps-1.71-1.08-1.06-5.02
Basicepscont-1.71-1.08-1.06-5.02
Dileps-1.71-1.08-1.06-5.02
Dilepscont-1.71-1.08-1.06
Intinc14 M11 M2 M84000.0
Netincdisc-102 M-52 M-43 M-101 M
Othincexp-1 M1 M-11000.081 M
Pretaxinc-98 M-52 M-43 M-101 M
Resdev94 M42 M32 M12 M
Sga20 M19 M13 M7 M
Shsout61 M60 M41 M40 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

Professional Trader